CABA
Cabaletta Bio, Inc.
Company overview
- Market capitalization
- $339.09M
- Employees
- 156
- Latest publication
- 2026-09-29
About Cabaletta Bio, Inc.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has collaborations with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,638,000USD | 0USD | 0USD |
| Cost Of Revenue | 337,000USD | -1,298,000USD | 345,000USD | 468,000USD | 485,000USD | 468,000USD | 424,000USD | 426,000USD |
| Gross Profit | -337,000USD | 1,298,000USD | -345,000USD | -468,000USD | -485,000USD | -468,000USD | -424,000USD | -426,000USD |
| Research Development | 37,353,000USD | 36,194,000USD | 39,824,000USD | 37,638,000USD | 29,018,000USD | 25,532,000USD | 26,290,000USD | 23,427,000USD |
| Selling General Administrative | 6,943,000USD | 6,417,000USD | 6,764,000USD | 8,268,000USD | 8,118,000USD | 8,253,000USD | 6,756,000USD | 6,852,000USD |
| Total Operating Expenses | 44,296,000USD | 42,611,000USD | 46,588,000USD | 45,906,000USD | 37,136,000USD | 33,785,000USD | 33,046,000USD | 30,279,000USD |
| Operating Income | -44,296,000USD | -42,611,000USD | -46,588,000USD | -45,906,000USD | -37,136,000USD | -33,785,000USD | -33,046,000USD | -30,279,000USD |
| Interest Income | 1,076,000USD | 1,326,000USD | 1,808,000USD | 1,410,000USD | 1,487,000USD | 1,947,000USD | 2,417,000USD | 2,677,000USD |
| Interest Expense | 636,000USD | 555,000USD | 584,000USD | 571,000USD | 294,000USD | 748,000USD | 0USD | 0USD |
| Net Interest Income | 440,000USD | 771,000USD | 1,224,000USD | 839,000USD | 1,193,000USD | 1,199,000USD | 2,417,000USD | 2,677,000USD |
| Income Before Tax | -43,515,000USD | -41,919,000USD | -44,866,000USD | -45,128,000USD | -35,943,000USD | -32,586,000USD | -30,629,000USD | -27,602,000USD |
| Net Income | -43,515,000USD | -41,919,000USD | -44,866,000USD | -45,128,000USD | -35,943,000USD | -32,586,000USD | -30,629,000USD | -27,602,000USD |
| Net Income From Continuing Ops | -43,515,000USD | -41,919,000USD | -44,866,000USD | -45,128,000USD | -35,943,000USD | -32,586,000USD | -30,629,000USD | -27,602,000USD |
| Ebit | -42,879,000USD | -41,364,000USD | -44,282,000USD | -44,557,000USD | -35,649,000USD | -23,760,000USD | -30,629,000USD | -27,602,000USD |
| Ebitda | -42,542,000USD | -41,016,000USD | -43,937,000USD | -44,089,000USD | -35,164,000USD | -23,292,000USD | -30,205,000USD | -27,176,000USD |
| Depreciation And Amortization | 337,000USD | 348,000USD | 345,000USD | 468,000USD | 485,000USD | 468,000USD | 424,000USD | 426,000USD |
| Reconciled Depreciation | 337,000USD | 348,000USD | 345,000USD | 468,000USD | 485,000USD | 468,000USD | 424,000USD | 426,000USD |
| Total Other Income Expense Net | 781,000USD | 692,000USD | 1,722,000USD | 778,000USD | 1,193,000USD | 1,199,000USD | 2,417,000USD | 2,677,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 393,000USD | — | 426,000USD |
| Income Tax Expense | — | — | — | — | — | -350,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,646,000USD | 4,813,000USD | 1,426,000USD | 3,684,000USD | 733,000USD | 354,000USD | 104,000USD | — |
| Gross Profit | -1,646,000USD | -4,813,000USD | -1,426,000USD | -3,684,000USD | -733,000USD | 0USD | -104,000USD | — |
| Research Development | 142,674,000USD | 97,203,000USD | 55,424,000USD | 39,300,000USD | 32,494,000USD | 21,376,000USD | 11,671,000USD | 4,467,000USD |
| Selling General Administrative | 29,567,000USD | 27,938,000USD | 19,236,000USD | 14,839,000USD | 13,819,000USD | 12,457,000USD | 7,012,000USD | 1,726,000USD |
| Total Operating Expenses | 172,241,000USD | 125,141,000USD | 74,660,000USD | 54,139,000USD | 46,313,000USD | 33,833,000USD | 18,683,000USD | 6,193,000USD |
| Operating Income | -172,241,000USD | -125,141,000USD | -74,660,000USD | -54,139,000USD | -46,313,000USD | -33,833,000USD | -18,683,000USD | -6,193,000USD |
| Interest Income | 6,031,000USD | 10,025,000USD | 6,985,000USD | 1,164,000USD | 24,000USD | 494,000USD | 1,740,000USD | 235,000USD |
| Interest Expense | 2,004,000USD | 748,000USD | 0USD | 1,178,000USD | 733,000USD | 494,000USD | 0USD | 0USD |
| Net Interest Income | 4,027,000USD | 9,277,000USD | 6,985,000USD | 1,164,000USD | 24,000USD | 494,000USD | 1,740,000USD | 235,000USD |
| Income Before Tax | -167,856,000USD | -115,864,000USD | -67,675,000USD | -52,975,000USD | -46,289,000USD | -33,339,000USD | -16,943,000USD | -12,202,000USD |
| Net Income | -167,856,000USD | -115,864,000USD | -67,675,000USD | -51,811,000USD | -45,532,000USD | -32,491,000USD | -15,099,000USD | -12,202,000USD |
| Net Income From Continuing Ops | -167,856,000USD | -115,864,000USD | -67,675,000USD | -52,975,000USD | -46,289,000USD | -33,339,000USD | -16,943,000USD | -12,202,000USD |
| Ebit | -165,852,000USD | -115,116,000USD | -67,675,000USD | -54,139,000USD | -46,313,000USD | -33,833,000USD | -18,683,000USD | -6,193,000USD |
| Ebitda | -164,206,000USD | -113,405,000USD | -66,249,000USD | -52,961,000USD | -45,580,000USD | -33,479,000USD | -18,579,000USD | -12,202,000USD |
| Depreciation And Amortization | 1,646,000USD | 1,711,000USD | 1,426,000USD | 1,178,000USD | 733,000USD | 354,000USD | 104,000USD | -6,009,000USD |
| Reconciled Depreciation | 1,646,000USD | 1,711,000USD | 1,426,000USD | 1,178,000USD | 733,000USD | 354,000USD | 104,000USD | — |
| Total Other Income Expense Net | 4,385,000USD | 9,277,000USD | 6,985,000USD | 1,164,000USD | 24,000USD | 494,000USD | 1,740,000USD | -6,244,000USD |
| Income Tax Expense | — | — | — | -1,164,000USD | -757,000USD | -848,000USD | -1,844,000USD | -235,000USD |
| Non Operating Income Net Other | — | — | — | 1,164,000USD | — | 494,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -52,975,000USD | -46,289,000USD | -33,339,000USD | -22,269,000USD | -12,202,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 256,728,000USD | 148,146,000USD | 165,083,000USD | 189,759,000USD | 224,500,000USD | 165,141,000USD | 185,046,000USD | 204,410,000USD |
| Cash And Equivalents | 225,101,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 225,101,000USD | 116,635,000USD | 133,599,000USD | 159,931,000USD | 194,682,000USD | 131,830,000USD | 163,962,000USD | 183,012,000USD |
| Short Term Investments | 0USD | 0USD | 50,617,000USD | 99,725,000USD | 49,070,000USD | — | 0USD | 12,404,000USD |
| Total Current Assets | 231,031,000USD | 122,316,000USD | 138,871,000USD | 164,561,000USD | 198,407,000USD | 134,596,000USD | 166,675,000USD | 185,515,000USD |
| Other Current Assets | 5,930,000USD | 5,681,000USD | 5,272,000USD | 4,630,000USD | 3,725,000USD | 2,766,000USD | 2,713,000USD | 2,503,000USD |
| Other Non Current Assets | 6,207,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 46,135,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 39,910,000USD | 41,507,000USD | 50,153,000USD | 45,735,000USD | 41,540,000USD | 33,989,000USD | 27,086,000USD | 22,882,000USD |
| Other Current Liabilities | 60,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 210,593,000USD | 103,305,000USD | 112,051,000USD | 139,466,000USD | 178,481,000USD | 121,553,000USD | 152,335,000USD | 174,241,000USD |
| Total Equity Including Noncontrolling Interest | 210,593,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 7,161,000USD | 20,557,000USD | 21,053,000USD | 21,591,000USD | 23,591,000USD | 28,176,000USD | 16,078,000USD | 16,413,000USD |
| Accounts Payable | 5,813,000USD | 6,382,000USD | 6,636,000USD | 8,267,000USD | 7,193,000USD | 6,492,000USD | 4,923,000USD | 2,180,000USD |
| Short Term Debt | 4,250,000USD | 23,116,000USD | 24,219,000USD | 21,222,000USD | 20,414,000USD | 19,194,000USD | 9,975,000USD | 7,937,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | — |
| Retained Earnings | -611,490,000USD | -560,472,000USD | -516,957,000USD | -475,038,000USD | -430,172,000USD | -385,044,000USD | -349,101,000USD | -316,515,000USD |
| Accumulated Other Comprehensive Income | 0USD | — | 25,000USD | 23,000USD | 1,000USD | — | — | 1,000USD |
| Total Liab | — | 44,841,000USD | 53,032,000USD | 50,293,000USD | 46,019,000USD | 43,588,000USD | 32,711,000USD | 30,169,000USD |
| Other Current Liab | — | 12,009,000USD | 19,298,000USD | 16,246,000USD | 13,933,000USD | 8,303,000USD | 12,188,000USD | 12,765,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 0USD |
| Cash | — | 116,635,000USD | 82,982,000USD | 60,206,000USD | 145,612,000USD | 131,830,000USD | 163,962,000USD | 170,608,000USD |
| Net Debt | — | -90,185,000USD | -55,884,000USD | -34,426,000USD | -120,719,000USD | -103,037,000USD | -148,362,000USD | -155,384,000USD |
| Short Long Term Debt Total | — | 26,450,000USD | 27,098,000USD | 25,780,000USD | 24,893,000USD | 28,793,000USD | 15,600,000USD | 15,224,000USD |
| Property Plant Equipment Gross | — | 20,557,000USD | 28,205,000USD | 21,591,000USD | 23,591,000USD | 28,176,000USD | 21,584,000USD | 16,413,000USD |
| Common Stock Shares Outstanding | — | 112,025,474shares | 102,262,904shares | 102,262,904shares | 61,876,586shares | 49,471,000shares | 50,198,000shares | 49,471,000shares |
| Non Current Assets Total | — | 25,829,999USD | 26,212,000USD | 25,198,000USD | 26,093,000USD | 30,545,000USD | 22,309,000USD | 18,895,000USD |
| Non Current Liabilities Total | — | 3,334,000USD | 2,879,000USD | 4,558,000USD | 4,479,000USD | 9,599,000USD | 5,625,000USD | 7,287,000USD |
| Non Currrent Assets Other | — | 5,272,999USD | 5,159,000USD | 3,607,000USD | 2,502,000USD | 2,369,000USD | 6,231,000USD | 2,482,000USD |
| Net Working Capital | — | 80,809,000USD | 88,718,000USD | 118,826,000USD | 156,867,000USD | 100,607,000USD | 139,589,000USD | 162,633,000USD |
| Unclassified Non Current Liabilities | — | 3,334,000USD | 2,879,000USD | 4,558,000USD | 4,479,000USD | 9,599,000USD | 5,625,000USD | 7,287,000USD |
| Unclassified Equity | — | 663,775,000USD | 628,981,000USD | 614,479,000USD | 608,650,000USD | 506,595,000USD | 501,434,000USD | 490,755,000USD |
| Other Assets | — | — | — | — | — | — | -3,938,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 165,083,000USD | 185,046,000USD | 253,650,000USD | 116,968,000USD | 126,336,000USD | 114,724,000USD | 141,468,000USD | 34,174,000USD |
| Other Current Assets | 5,272,000USD | 2,713,000USD | 3,241,000USD | 2,287,000USD | 2,319,000USD | 4,873,000USD | 4,348,000USD | 93,000USD |
| Total Liab | 53,032,000USD | 32,711,000USD | 17,452,000USD | 12,448,000USD | 8,380,000USD | 5,180,000USD | 3,147,000USD | 44,864,000USD |
| Total Stockholder Equity | 112,051,000USD | 152,335,000USD | 236,198,000USD | 104,520,000USD | 117,956,000USD | 109,544,000USD | 138,321,000USD | -10,690,000USD |
| Other Current Liab | 19,298,000USD | 12,188,000USD | 7,887,000USD | 4,847,000USD | 6,047,000USD | 3,937,000USD | 2,227,000USD | 340,000USD |
| Common Stock | 1,000USD | 1,000USD | — | — | — | — | — | — |
| Capital Stock | 1,000USD | 1,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -516,957,000USD | -349,101,000USD | -233,237,000USD | -165,562,000USD | -112,587,000USD | -66,298,000USD | -32,959,000USD | -12,452,000USD |
| Cash | 82,982,000USD | 163,962,000USD | 193,238,000USD | 81,607,000USD | 122,222,000USD | 101,429,000USD | 136,204,000USD | 33,017,000USD |
| Cash And Short Term Investments | 133,599,000USD | 163,962,000USD | 241,249,000USD | 106,547,000USD | 122,222,000USD | 108,662,000USD | 136,204,000USD | 33,017,000USD |
| Total Current Assets | 138,871,000USD | 166,675,000USD | 244,490,000USD | 108,834,000USD | 124,541,000USD | 113,535,000USD | 140,552,000USD | 33,994,000USD |
| Total Current Liabilities | 50,153,000USD | 27,086,000USD | 15,994,000USD | 9,489,000USD | 8,380,000USD | 5,180,000USD | 3,147,000USD | 943,000USD |
| Net Debt | -55,884,000USD | -148,362,000USD | -188,220,000USD | -76,469,000USD | -122,222,000USD | -101,429,000USD | -136,204,000USD | 10,904,000USD |
| Short Term Debt | 24,219,000USD | 9,975,000USD | 3,560,000USD | 2,179,000USD | — | — | — | — |
| Short Long Term Debt Total | 27,098,000USD | 15,600,000USD | 5,018,000USD | 5,138,000USD | — | — | — | 43,921,000USD |
| Short Term Investments | 50,617,000USD | 0USD | 48,011,000USD | 24,940,000USD | 0USD | 7,233,000USD | — | — |
| Accounts Payable | 6,636,000USD | 4,923,000USD | 4,547,000USD | 2,463,000USD | 2,333,000USD | 1,243,000USD | 920,000USD | 603,000USD |
| Property Plant Equipment Net | 21,053,000USD | 16,078,000USD | 7,451,000USD | 7,569,000USD | 1,438,000USD | 890,000USD | 815,000USD | — |
| Property Plant Equipment Gross | 28,205,000USD | 21,584,000USD | 11,246,000USD | 9,938,000USD | 2,629,000USD | 890,000USD | 815,000USD | — |
| Accumulated Other Comprehensive Income | 25,000USD | — | 39,000USD | -47,000USD | — | 6,000USD | -104,000USD | — |
| Common Stock Shares Outstanding | 102,262,904shares | 49,471,000shares | 40,946,000shares | 29,343,000shares | 25,737,000shares | 23,145,000shares | 5,469,000shares | 14,512,000shares |
| Non Current Assets Total | 26,212,000USD | 22,309,000USD | 9,160,000USD | 8,134,000USD | 1,795,000USD | 1,189,000USD | 916,000USD | 180,000USD |
| Non Current Liabilities Total | 2,879,000USD | 5,625,000USD | 1,458,000USD | 2,959,000USD | 2,333,000USD | 1,243,000USD | 920,000USD | 43,921,000USD |
| Non Currrent Assets Other | 5,159,000USD | 6,231,000USD | 1,709,000USD | 565,000USD | 357,000USD | 299,000USD | 101,000USD | 180,000USD |
| Net Working Capital | 88,718,000USD | 139,589,000USD | 228,496,000USD | 99,345,000USD | 116,161,000USD | 108,355,000USD | 137,405,000USD | 33,051,000USD |
| Unclassified Non Current Liabilities | 2,879,000USD | 5,625,000USD | 1,458,000USD | 2,959,000USD | 2,333,000USD | 1,243,000USD | — | 43,741,000USD |
| Unclassified Equity | 628,981,000USD | 501,434,000USD | 469,396,000USD | 270,129,000USD | 230,543,000USD | 175,836,000USD | 171,384,000USD | 1,762,000USD |
| Other Assets | — | -3,938,000USD | 1USD | 565,000USD | 357,000USD | 299USD | 101,000USD | 180,000USD |
| Net Tangible Assets | — | — | — | 104,520,000USD | 116,615,000USD | 109,544,000USD | 138,321,000USD | -10,690,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 180,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 708,000USD |
| Stock Based Compensation | 10,755,000USD |
| Change To Liabilities | -5,861,000USD |
| Change In Working Capital | -2,883,000USD |
| Operating Cash Flow | -84,075,000USD |
| Capital Expenditures | 0USD |
| Net Investments | 50,960,000USD |
| Investing Cash Flow | 50,960,000USD |
| Net Debt Issuance | -7,091,000USD |
| Unclassified Financing Cash Flow | 182,345,000USD |
| Financing Cash Flow | 175,254,000USD |
| Effect Of Forex Changes On Cash | -20,000USD |
| Change In Cash | 142,119,000USD |
| End Cash Flow | 225,101,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -43,515,000USD | -41,919,000USD | -44,866,000USD | -45,128,000USD | -35,943,000USD | -32,586,000USD | -30,629,000USD | -27,602,000USD |
| Depreciation | 337,000USD | 348,000USD | 345,000USD | 468,000USD | 485,000USD | 468,000USD | 424,000USD | 426,000USD |
| Stock Based Compensation | 5,256,000USD | 4,258,000USD | 5,815,000USD | 5,705,000USD | 5,161,000USD | 5,411,000USD | 5,250,000USD | 5,013,000USD |
| Other Non Cash Items | 4,732,000USD | 3,582,000USD | 3,982,000USD | 4,464,000USD | 2,542,000USD | 711,000USD | 1,734,000USD | 1,405,000USD |
| Change In Working Capital | -9,371,000USD | -1,612,000USD | 215,000USD | 4,065,000USD | -3,047,000USD | 2,874,000USD | 2,898,000USD | -31,000USD |
| Total Cash From Operating Activities | -42,561,000USD | -35,343,000USD | -34,509,000USD | -30,426,000USD | -30,802,000USD | -23,122,000USD | -20,323,000USD | -20,789,000USD |
| Capital Expenditures | 0USD | -205,000USD | -78,000USD | -161,000USD | -785,000USD | -376,000USD | -253,000USD | -770,000USD |
| Free Cash Flow | -42,561,000USD | -35,548,000USD | -34,587,000USD | -30,587,000USD | -31,587,000USD | -23,498,000USD | -20,576,000USD | -21,559,000USD |
| Investments | 50,960,000USD | 50,000,000USD | -50,080,000USD | -49,196,000USD | -785,000USD | 12,124,000USD | 12,247,000USD | 23,730,000USD |
| Total Cashflows From Investing Activities | 50,960,000USD | 49,795,000USD | -50,080,000USD | -49,196,000USD | -785,000USD | 12,124,000USD | 12,247,000USD | 23,730,000USD |
| Net Borrowings | -4,271,000USD | -1,912,000USD | -795,000USD | -3,002,000USD | -552,000USD | — | 0USD | — |
| Total Cash From Financing Activities | 25,267,000USD | 8,332,000USD | -806,000USD | 93,373,000USD | -552,000USD | 4,372,000USD | 71,000USD | 379,000USD |
| Issuance Of Capital Stock | 22,568,000USD | 10,150,000USD | -25,000USD | 96,178,000USD | 0USD | 5,129,000USD | 0USD | 0USD |
| Change In Cash | 33,653,000USD | 22,776,000USD | -85,406,000USD | 13,782,000USD | -32,132,000USD | -6,646,000USD | -8,005,000USD | 3,320,000USD |
| Begin Period Cash Flow | 82,982,000USD | 60,206,000USD | 145,612,000USD | 131,830,000USD | 163,962,000USD | 170,608,000USD | 178,613,000USD | 175,293,000USD |
| End Period Cash Flow | 116,635,000USD | 82,982,000USD | 60,206,000USD | 145,612,000USD | 131,830,000USD | 163,962,000USD | 170,608,000USD | 178,613,000USD |
| Unclassified Financing Cash Flow | 6,970,000USD | 16,214,000USD | — | — | — | -6,783,000USD | 5,688,000USD | — |
| Sale Purchase Of Stock | — | 291,000USD | 197,000USD | — | — | 140,000USD | 129,000USD | — |
| Other Cashflows From Financing Activities | — | -6,261,000USD | 14,000USD | 197,000USD | — | 11,015,000USD | -5,746,000USD | 379,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -167,856,000USD | -115,864,000USD | -67,675,000USD | -46,289,000USD | -33,339,000USD | -12,202,000USD | -333,333USD |
| Depreciation | 1,646,000USD | 1,711,000USD | 1,426,000USD | 733,000USD | 354,000USD | 104,000USD | 104,000USD |
| Stock Based Compensation | 20,939,000USD | 19,465,000USD | 11,343,000USD | 5,804,000USD | 4,388,000USD | 606,000USD | — |
| Other Non Cash Items | 14,570,000USD | 4,855,000USD | 1,256,000USD | 62,000USD | 119,000USD | 7,399,000USD | 252,000USD |
| Change In Working Capital | -379,000USD | 1,611,000USD | 101,000USD | 5,581,000USD | 1,708,000USD | -464,000USD | 81,333USD |
| Total Cash From Operating Activities | -131,080,000USD | -88,222,000USD | -53,549,000USD | -34,109,000USD | -26,770,000USD | -4,661,000USD | -4,661,000USD |
| Capital Expenditures | -1,229,000USD | -2,211,000USD | -687,000USD | -1,166,000USD | -635,000USD | -693,000USD | -693,000USD |
| Free Cash Flow | -132,309,000USD | -90,433,000USD | -54,236,000USD | -35,275,000USD | -27,405,000USD | -4,661,000USD | — |
| Investments | -49,037,000USD | 47,289,000USD | -22,451,000USD | 7,165,000USD | -7,981,000USD | -7,346,000USD | -7,346,000USD |
| Total Cashflows From Investing Activities | -50,266,000USD | 47,289,000USD | -22,451,000USD | 5,999,000USD | -7,981,000USD | -693,000USD | -693,000USD |
| Net Borrowings | -6,261,000USD | -897,000USD | 0USD | — | — | 12,535,000USD | 12,535,000USD |
| Total Cash From Financing Activities | 100,347,000USD | 11,677,000USD | 187,631,000USD | 48,903,000USD | -24,000USD | 37,677,000USD | 1,333USD |
| Sale Purchase Of Stock | 291,000USD | 269,000USD | 108,000USD | 71,000USD | -192,000USD | -169,000USD | 1,000USD |
| Issuance Of Capital Stock | 106,303,000USD | 10,875,000USD | 185,202,000USD | 48,324,000USD | 29,000USD | 25,311,000USD | — |
| Change In Cash | -80,980,000USD | -29,276,000USD | 111,631,000USD | 20,793,000USD | -34,775,000USD | 33,016,000USD | 1,333USD |
| Begin Period Cash Flow | 163,962,000USD | 193,238,000USD | 81,607,000USD | 101,429,000USD | 136,204,000USD | 1,000USD | -1,332USD |
| End Period Cash Flow | 82,982,000USD | 163,962,000USD | 193,238,000USD | 122,222,000USD | 101,429,000USD | 33,017,000USD | 1USD |
| Other Cashflows From Financing Activities | 100,347,000USD | 1,699,000USD | 2,429,000USD | 650,000USD | 168,000USD | 25,142,000USD | 1,333USD |
| Unclassified Financing Cash Flow | 5,970,000USD | 10,606,000USD | 185,094,000USD | 48,182,000USD | — | — | -12,536,000USD |
| Unclassified Investing Cash Flow | — | 2,211,000USD | — | — | — | 7,346,000USD | 7,346,000USD |
| Change To Liabilities | — | — | — | 975,000USD | 555,000USD | 234,000USD | 252,000USD |
| Other Cashflows From Investing Activities | — | — | — | 7,165USD | -7,346USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | — | -34,775,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -4,765,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.